HCPCS Code Q5118: Injection, Bevacizumab-bvzr, Biosimilar, (Zirabev), 10 mg

HCPCS Code Q5118: Injection, Bevacizumab-bvzr, Biosimilar, (Zirabev), 10 mg

Learn about the HCPCS code Q5118 for "Injection, bevacizumab-bvzr, biosimilar, (Zirabev), 10 mg" through this short guide.

Use Code

Frequently asked questions

It'll likely take an hour and 30 minutes since it's an intravenous injection. Subsequent doses should take anywhere between 30 minutes and an hour.

There will be pain and discomfort in the IV site. Common side effects include hypertension, nausea, fatigue, and bleeding. The ones you have to really watch out for are the development of blood clots, heart problems, severe bleeding, and gastrointestinal perforations. These are rare, but this is why patient monitoring is important after the infusion.

Other treatments that can be considered are radiation therapy, other chemotherapy drugs, or, if viable, surgery.

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments